Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C15H11ClO2 |
| Molecular Weight | 258.7 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(C1=CC2=C(O1)C=CC=C2)C3=CC=C(Cl)C=C3
InChI
InChIKey=KBFBRIPYVVGWRS-UHFFFAOYSA-N
InChI=1S/C15H11ClO2/c16-12-7-5-10(6-8-12)15(17)14-9-11-3-1-2-4-13(11)18-14/h1-9,15,17H
| Molecular Formula | C15H11ClO2 |
| Molecular Weight | 258.7 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Cloridarol is a vasodilator that was studied for the treatment of coronary insufficiency in Italy in the 1970s. In normolipidemic rats, cloridarol decreased plasma triglycerides without affecting cholesterolemia and fast- or norepinephrine-induced lipolysis. The drug proved effective in reducing fructose-induced hypertriglyceridemia and dietary hypercholesterolemia in rats.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:37:21 GMT 2023
by
admin
on
Sat Dec 16 18:37:21 GMT 2023
|
| Record UNII |
JXI9IO55VI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
JXI9IO55VI
Created by
admin on Sat Dec 16 18:37:21 GMT 2023 , Edited by admin on Sat Dec 16 18:37:21 GMT 2023
|
PRIMARY | |||
|
1290045-29-2
Created by
admin on Sat Dec 16 18:37:21 GMT 2023 , Edited by admin on Sat Dec 16 18:37:21 GMT 2023
|
PRIMARY |